Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

DER AKTIONÄR

December 4, 2019

Biotech secret tip Abivax Takes off: Monster target price – a share for 2020?

Empowered Patient Podcast

June 5, 2019

Unique Therapy for Multiple Inflammatory Diseases with Dr. Jean-Marc Steens Abivax

MD Magazine

May 23, 2019

ABX464 as a Treatment for Ulcerative Colitis

San Diego Union Tribune

May 14, 2019

Experimental liver cancer drug developed at Scripps Research cleared for testing

Labiotech

March 8, 2019

HIV Drug Shows Promise for Treating Ulcerative Colitis Patients

  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 46

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn